Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Nov 16, 2017; 9(11): 558-560
Published online Nov 16, 2017. doi: 10.4253/wjge.v9.i11.558
Published online Nov 16, 2017. doi: 10.4253/wjge.v9.i11.558
Table 1 Demographic and anthropometric characteristics n (%)
| Standard preparation (2 L PEG-ASC) (n = 30) | Prucalopride + 1 L PEG-ASC (n = 30) | |
| Age median (range) | 53 (46-67) | 55 (48-64) |
| Sex | 14 (47) | 14 (47) |
| BMI median (range) | 26.7 (18.4-32.8) | 25.4 (17.3-31) |
| Boston scale ≥ 7 | 26 (87) | 25 (83) |
| Boston scale ≤ 6 | 4 (13) | 5 (17) |
| Exam indication | ||
| Screening | 18 (60) | 16 (53) |
| Follow up | 12 (40) | 14 (47) |
| Adenoma detection rate (%) | 32 | 29 |
| Time to preparation (h) median (range) | 11.30 (10.45-12.30) | 11.45 (10.30-12.45) |
| Colonoscopy insertion time (min), median (range) | 8.2 (3.3-36) | 7.6 (3.1-47) |
- Citation: Corleto VD, Antonelli G, Coluccio C, D’Alba L, di Giulio E. Efficacy of Prucalopride in bowel cleansing before colonoscopy: Results of a pilot study. World J Gastrointest Endosc 2017; 9(11): 558-560
- URL: https://www.wjgnet.com/1948-5190/full/v9/i11/558.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i11.558